| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
|
Kanasty, Rosemary L
|
|
2012
|
20 |
3 |
p. 513-524
12 p.
|
article
|
| 2 |
A General RNA Motif for Cellular Transfection
|
Magalhães, Maria LB
|
|
2012
|
20 |
3 |
p. 616-624
9 p.
|
article
|
| 3 |
An Artificial PAP Gene Breaks Self-tolerance and Promotes Tumor Regression in the TRAMP Model for Prostate Carcinoma
|
Spies, Elmar
|
|
2012
|
20 |
3 |
p. 555-564
10 p.
|
article
|
| 4 |
Cell-penetrating Peptides as Versatile Vehicles for Oligonucleotide Delivery
|
Margus, Helerin
|
|
2012
|
20 |
3 |
p. 525-533
9 p.
|
article
|
| 5 |
Clinical Development of Advanced Therapy Medicinal Products in Europe: Evidence That Regulators Must Be Proactive
|
Maciulaitis, Romaldas
|
|
2012
|
20 |
3 |
p. 479-482
4 p.
|
article
|
| 6 |
Combined Tbet and IL12 Gene Therapy Elicits and Recruits Superior Antitumor Immunity In Vivo
|
Qu, Yanyan
|
|
2012
|
20 |
3 |
p. 644-651
8 p.
|
article
|
| 7 |
Concomitant Intravenous Nitroglycerin With Intracoronary Delivery of AAV1.SERCA2a Enhances Gene Transfer in Porcine Hearts
|
Karakikes, Ioannis
|
|
2012
|
20 |
3 |
p. 565-571
7 p.
|
article
|
| 8 |
Correction of Murine Bernard–Soulier Syndrome by Lentivirus-mediated Gene Therapy
|
Kanaji, Sachiko
|
|
2012
|
20 |
3 |
p. 625-632
8 p.
|
article
|
| 9 |
Efficient Gene Therapy for Parkinson's Disease Using Astrocytes as Hosts for Localized Neurotrophic Factor Delivery
|
Drinkut, Anja
|
|
2012
|
20 |
3 |
p. 534-543
10 p.
|
article
|
| 10 |
Escaping the Valley of Death
|
Frederickson, Robert M
|
|
2012
|
20 |
3 |
p. 476-478
3 p.
|
article
|
| 11 |
Hepatitis C Virus NS3/NS4A DNA Vaccine Induces Multiepitope T Cell Responses in Rhesus Macaques Mimicking Human Immune Responses
|
Lang Kuhs, Krystle A
|
|
2012
|
20 |
3 |
p. 669-678
10 p.
|
article
|
| 12 |
In This Issue
|
|
|
2012
|
20 |
3 |
p. 474-
1 p.
|
article
|
| 13 |
In Vivo Delivery of Nucleic Acids via Glycopolymer Vehicles Affords Therapeutic Infarct Size Reduction In Vivo
|
Tranter, Michael
|
|
2012
|
20 |
3 |
p. 601-608
8 p.
|
article
|
| 14 |
Long-term Persistence of CD4+ but Rapid Disappearance of CD8+ T Cells Expressing an MHC Class I-restricted TCR of Nanomolar Affinity
|
Engels, Boris
|
|
2012
|
20 |
3 |
p. 652-660
9 p.
|
article
|
| 15 |
Long-term Restoration of Cardiac Dystrophin Expression in Golden Retriever Muscular Dystrophy Following rAAV6-mediated Exon Skipping
|
Bish, Lawrence T
|
|
2012
|
20 |
3 |
p. 580-589
10 p.
|
article
|
| 16 |
NF-κB Negatively Impacts the Myogenic Potential of Muscle-derived Stem Cells
|
Lu, Aiping
|
|
2012
|
20 |
3 |
p. 661-668
8 p.
|
article
|
| 17 |
Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer
|
Senzer, Neil
|
|
2012
|
20 |
3 |
p. 679-686
8 p.
|
article
|
| 18 |
Progress Toward In Vivo Use of siRNAs-II
|
Rettig, Garrett R
|
|
2012
|
20 |
3 |
p. 483-512
30 p.
|
article
|
| 19 |
Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor
|
Lanitis, Evripidis
|
|
2012
|
20 |
3 |
p. 633-643
11 p.
|
article
|
| 20 |
Research Highlights
|
|
|
2012
|
20 |
3 |
p. 475-
1 p.
|
article
|
| 21 |
Self-complementary AAVs Induce More Potent Transgene Product-specific Immune Responses Compared to a Single-stranded Genome
|
Wu, TeLang
|
|
2012
|
20 |
3 |
p. 572-579
8 p.
|
article
|
| 22 |
Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine Model
|
Gombash, Sara E
|
|
2012
|
20 |
3 |
p. 544-554
11 p.
|
article
|
| 23 |
Sustained miRNA-mediated Knockdown of Mutant AAT With Simultaneous Augmentation of Wild-type AAT Has Minimal Effect on Global Liver miRNA Profiles
|
Mueller, Christian
|
|
2012
|
20 |
3 |
p. 590-600
11 p.
|
article
|
| 24 |
Systemic Delivery of siRNA via LCP Nanoparticle Efficiently Inhibits Lung Metastasis
|
Yang, Yang
|
|
2012
|
20 |
3 |
p. 609-615
7 p.
|
article
|
| 25 |
The Need for Increased Clarity and Transparency in the Regulatory Pathway for Gene Medicines in the European Union
|
Ylä-Herttuala, Seppo
|
|
2012
|
20 |
3 |
p. 471-472
2 p.
|
article
|
Journal description